GENETIC STUDIES OF CROHN'S DISEASE AND ULCERATIVE COLITIS
克罗恩病和溃疡性结肠炎的遗传学研究
基本信息
- 批准号:6275620
- 负责人:
- 金额:$ 2.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-12-01 至 1998-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The inflammatory bowel diseases, Crohn's disease and ulcerative colitis,
are chronic frequently disabling inflammatory disorders of the small and
large intestines. Despite extensive immunologic, pathologic and
microbiologic reseerch, the etiology remains unknown, and the
pathophysiology is poorly understood. Medical therapy is suboptimal and
often associated with considerable morbidity. The risk of colorectal
cancer is significantly increased for both disorders.
There is strong evidence from twin studies, studies of familial
aggregation and ethnic differences in disese prevalence that the
inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative
colitis (UC), are in large part genetic. The disorders are categorized
as complex genetic disorders, since inheritance does not follow simple
Mendelian patterns. In comparison with other complex genetic disorders
the degree of genetic clustering in siblings, expressed as ns and
defined as the increased risk over population prevalence for a sibling
of a proband, is relatively large. ns for CD, UC and IBD have been
estimated at 36.5, 16.6 and 24.7, respectively, comparatively greater
than that for other disorders where susceptibility genes have been
better established, such as IDDM and schizophrenia where ns is 15 and
8.6, respectively. CD and UC are genetically related as the cross
disease relative risk is 3.85 with a CD proband and 1.72 with a UC
proband.
Our genetic studies on IBD are based on the hypothesis that there are
specific susceptibility genes which are responsible for the familial
clustering of these diseases. Susceptibility gene identification will
allow an understanding of the initial pathophysiologic mechanisrns, and
thus make it possible to design better medical therapy and better
predict the disease course.
炎症性肠病、克罗恩病和溃疡性结肠炎,
是慢性经常致残性炎症性疾病的小,
大肠尽管广泛的免疫,病理和
微生物学研究,病因仍然未知,
病理生理学知之甚少。药物治疗不理想,
通常与相当大的发病率有关。结肠直肠癌的风险
这两种疾病的癌症显著增加。
有强有力的证据来自双胞胎研究,
疾病流行率的聚集和种族差异,
炎症性肠病(IBD)、克罗恩病(CD)和溃疡性结肠炎(UC)
结肠炎(UC)在很大程度上是遗传性的。这些疾病被分类为
复杂的遗传疾病,因为遗传并不遵循简单的
孟德尔模式。与其他复杂的遗传疾病相比,
兄弟姐妹的遗传聚集程度,表示为NS和
定义为兄弟姐妹的患病风险高于人群患病率
先证者的遗传变异相对较大 对于CD、UC和IBD,
估计分别为36.5、16.6和24.7,
而对于其他疾病,易感基因
更好地建立,如胰岛素依赖型糖尿病和精神分裂症,其中ns为15,
8.6分别。CD和UC在遗传上是交叉相关的
CD先证者的疾病相对风险为3.85,UC为1.72
先证者
我们对IBD的遗传学研究是基于以下假设:
特定的易感基因,负责家族性
这些疾病的聚集。易感基因鉴定将
允许理解最初的病理生理机制,和
从而使设计更好的医学治疗成为可能,
预测疾病进程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN BRANT其他文献
STEVEN BRANT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN BRANT', 18)}}的其他基金
GENETIC STUDIES OF CROHN'S DISEASE AND ULCERATIVE COLITIS
克罗恩病和溃疡性结肠炎的遗传学研究
- 批准号:
6114385 - 财政年份:1998
- 资助金额:
$ 2.01万 - 项目类别:
相似海外基金
A point of need clinical chemistry and hematology platform for improving accessibility to diagnostic testing
用于提高诊断测试可及性的临床化学和血液学平台需求点
- 批准号:
10757303 - 财政年份:2023
- 资助金额:
$ 2.01万 - 项目类别:
Establishment of a clinical chemistry test method using a medical agarose electrophoresis kit for captive Asian elephants.
建立圈养亚洲象医用琼脂糖电泳试剂盒临床化学检测方法。
- 批准号:
22K06008 - 财政年份:2022
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
IGF::OT::IGF "Follow-On 28 Day Dog Pharmacokinetic and Clinical Chemistry Assessments"- SRI International
IGF::OT::IGF“后续 28 天狗药代动力学和临床化学评估”- SRI International
- 批准号:
9589199 - 财政年份:2017
- 资助金额:
$ 2.01万 - 项目类别:
Development of rapid analysis method of drugs of abuse used for forensic science and clinical chemistry
用于法医学和临床化学的滥用药物快速分析方法的开发
- 批准号:
20590043 - 财政年份:2008
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
New evolution of clinical chemistry by mass spectrometry
质谱临床化学的新进展
- 批准号:
19590165 - 财政年份:2007
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SBIR Phase I: Bioluminescence Resonance Energy Transfer Assays for Clinical Chemistry
SBIR 第一阶段:临床化学生物发光共振能量转移测定
- 批准号:
0711621 - 财政年份:2007
- 资助金额:
$ 2.01万 - 项目类别:
Standard Grant
Clinical Chemistry of Newly-found Esterase for Endogenous Digitalis-like Factor
新发现的内源性洋地黄样因子酯酶的临床化学
- 批准号:
18590543 - 财政年份:2006
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clinical Chemistry of Newly-found Endogenous Bufalin Isomer in Saliva
唾液中新发现的内源性蟾蜍灵异构体的临床化学
- 批准号:
16590467 - 财政年份:2004
- 资助金额:
$ 2.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PRESENTATIONS AT 47TH ASMS CONFERENCE & WORKSHOP ON MS IN CLINICAL CHEMISTRY
第 47 届 ASMS 会议上的演讲
- 批准号:
6345191 - 财政年份:2000
- 资助金额:
$ 2.01万 - 项目类别:
PRESENTATIONS AT 47TH ASMS CONFERENCE & WORKSHOP ON MS IN CLINICAL CHEMISTRY
第 47 届 ASMS 会议上的演讲
- 批准号:
6478915 - 财政年份:2000
- 资助金额:
$ 2.01万 - 项目类别:














{{item.name}}会员




